Scarica l'app Stockscreener
2.11
4.46%
0.09
Dopo l'orario di chiusura:
2.10
-0.010
-0.47%
Precedente Chiudi:
$2.02
Aprire:
$2.01
Volume 24 ore:
259.04K
Relative Volume:
1.04
Capitalizzazione di mercato:
$97.70M
Reddito:
-
Utile/perdita netta:
$-123.57M
Rapporto P/E:
-0.6941
EPS:
-3.04
Flusso di cassa netto:
$-97.53M
1 W Prestazione:
+11.05%
1M Prestazione:
+9.33%
6M Prestazione:
+1.44%
1 anno Prestazione:
-85.22%
Intervallo 1D:
$1.99
$2.12
Intervallo di 1 settimana:
$1.89
$2.12
Portata 52W:
$1.34
$14.43
Hillevax Inc Stock (HLVX) Company Profile
Nome
Hillevax Inc
Settore
Industria
Telefono
(617) 213-5054
Indirizzo
321 HARRISON AVE, SUITE 500, BOSTON
Confronta HLVX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HLVX
Hillevax Inc
|
2.11 | 97.70M | 0 | -123.57M | -97.53M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Hillevax Inc Stock (HLVX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-09 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-09 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-07-09 | Downgrade | Stifel | Buy → Hold |
| 2024-07-08 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-07-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-12-13 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Hillevax Inc Borsa (HLVX) Ultime notizie
HilleVax, Inc. (NASDAQ:HLVX) Receives Consensus Rating of “Hold” from Analysts - Defense World
HilleVax, Inc. (NASDAQ:HLVX) Stake Boosted by Two Sigma Investments LP - Defense World
Two Sigma Advisers LP Purchases 17,900 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Millennium Management LLC Has $852,000 Stake in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Citadel Advisors LLC Has $245,000 Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
HilleVax, Inc. (NASDAQ:HLVX) is largely controlled by institutional shareholders who own 51% of the company - Yahoo Finance
HilleVax, Inc. (NASDAQ:HLVX) Given Average Rating of “Hold” by Brokerages - Defense World
What is HC Wainwright’s Forecast for HilleVax Q2 Earnings? - Defense World
Voya Investment Management LLC Has $127,000 Stock Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Barclays PLC Raises Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
HilleVax Reports Improved Financial Performance - TipRanks
HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress - Bluefield Daily Telegraph
JPMorgan Chase & Co. Acquires 193,124 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Geode Capital Management LLC Decreases Stock Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Potential Price Increase for HilleVax Inc (HLVX) After Recent Insider Activity - knoxdaily.com
HilleVax, Inc. (NASDAQ:HLVX) Receives $3.00 Average PT from Analysts - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
HilleVax, Inc. (NASDAQ:HLVX) Shares Bought by Russell Investments Group Ltd. - Defense World
Bank of Montreal Can Acquires 11,459 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Is HilleVax Inc (HLVX) worth investing in despite its overvalued state? - uspostnews.com
Frazier Life Sciences Appoints Aditya Kohli to Partner - Business Wire
GSI Technology And 2 Other Promising Penny Stocks For Your Watchlist - simplywall.st
ATTENTION HLVX SHAREHOLDERS: Investors who Lost Money on HilleVax, Inc. are Urged to Contact Levi & Korsinsky About an Ongoing Investigation - ACCESS Newswire
HKVX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
HilleVax, Inc. (NASDAQ:HLVX) Receives $3.00 Consensus Price Target from Brokerages - Defense World
HilleVax (NASDAQ:HLVX) Given Neutral Rating at HC Wainwright - Defense World
Cautious Hold Rating on HilleVax Amid Norovirus Vaccine Development Setbacks - TipRanks
HilleVax Reports 2024 Financial Results Amid Strategic Exploration - MSN
HilleVax Inc. (HLVX) reports earnings - Quartz
HilleVax, Inc. SEC 10-K Report - TradingView
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress - The Manila Times
Shareholder Rights Advocates at Levi & Korsinsky Investigate HilleVax, Inc. (HLVX) Regarding Possible Securities Fraud Violations - ACCESS Newswire
HilleVax (HLVX) to Release Quarterly Earnings on Wednesday - Defense World
HILLEVAX Earnings Preview: Recent $HLVX Insider Trading, Hedge Fund Activity, and More - Nasdaq
HilleVax (NASDAQ:HLVX) & Omega Therapeutics (NASDAQ:OMGA) Critical Survey - Defense World
HKVX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm! - ACCESS Newswire
Hillevax CFO Shane Maltbie sells $15,116 in stock By Investing.com - Investing.com Nigeria
Stocks of HilleVax Inc (HLVX) are poised to climb above their peers - SETE News
Hillevax CEO Robert Hershberg sells $48,661 in stock - MSN
HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by SG Americas Securities LLC - Defense World
Hillevax CFO Shane Maltbie sells $15,116 in stock - MSN
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Qiming U.S. Ventures Management LLC - MarketBeat
Top Executives Cash In on HilleVax Stock Sales - TipRanks
HilleVax Executives Sell Shares in February 2025 - TradingView
Hillevax Inc Azioni (HLVX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Hillevax Inc Azioni (HLVX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT | See Remarks |
Feb 11 '25 |
Sale |
1.76 |
11,901 |
21,003 |
1,101,498 |
| Maltbie Shane | Chief Financial Officer |
Feb 11 '25 |
Sale |
1.76 |
4,345 |
7,659 |
79,887 |
| Maltbie Shane | Chief Financial Officer |
Feb 04 '25 |
Sale |
1.89 |
3,946 |
7,458 |
84,232 |
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):